I covered VEVYE and IHEEZO in a pair of articles on Harrow (NASDAQ: HROW ), so it is time now to look at Triesence, the company’s latest relaunched molecule. So we will do that here. VEVYE and IHEEZO areAbout the TPT serviceThanks for reading. At the Total Pharma Tracker, we offer the following:-Our Android app and website features a set of tools for DIY investors, including a work-in-progress software where you can enter any ticker and get extensive curated research material. For investors requiring hands- ...